(13) demonstrates, however, that HER2 protects cancer cells from STING-mediated innate antitumor immunity by activating AKT1, suggesting that HER2 recruits AKT1 to lower STING signal, hence restricting anti-virus defense and anti-tumor immunity. The gene discussed is ERBB2; the disease is neoplasm.